MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis - Related Studies

MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis

This study has been completed.

Study NCT00076869. Last updated on May 17, 2007. Information provided by Merck

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Aspergillosis

2	More general conditions related to this trial
		Mycoses

3	Interventions listed in this trial
		MK0991, caspofungin acetate
		Comparator: amphotericin B

4	Additional drug interventions recognized in this trial
		Abelcet
		AmBisome
		Amphotericin B
		Caspofungin

5	More general drug interventions related to this trial
		Amebicides
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antifungal
		Antifungal Agents
		Antiparasitic Agents
		Antiprotozoal Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Merck